Antitetanus Vaccination for People Older Than 65 Years.

Tetanus Clinical Trial

— VAT65  

Official title:

Antitetanus Vaccination for People Older Than 65 Years in the Auvergne-Rhône-Alpes (France) Region Depending on the Demographic and Medical Practice of Their Medical Practitioner.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03266211
• Other study ID #: 69HCL17_0375
• Status: Completed
• Start date: November 9, 2017
• Est. completion date: December 23, 2017

Study information

• Verified date: August 2017
• Source: Hospices Civils de Lyon
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In the last ten years, more than one hundred generalized tetanus cases were declared in France. Most of them were affecting people older than 70 years with an important mortality (around 28%). It is know that the only way to protect ourselves from this disease is the vaccination. In France tetanus vaccination is mandatory since 1940.

Nowaday none study looked specifically for the vaccination of people older than 65 years. The hypothesis is: there is a difference in the tetanus vaccination coverage for people older than 65 years depending on the demographic and medical practice of their general practitioner.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 261
• Est. completion date: December 23, 2017
• Est. primary completion date: December 23, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients older than 65 years consulting their attending physician in and who agreed to participate in the study.

• The doctors included are general practitioners located in a liberal office in the "Auvergne Rhône Alpes" region for which the URPS ("Union régional des Professionnels de Santé") has an email address.

Exclusion Criteria:

Related Conditions & MeSH terms

• Tetanus

Intervention

Other:
• Questionnaire Patients
Patient will have to answer a quiz which is about their vaccination against tetanus.
• Questionnaire General practitioner
General practitioner will have to answer a quiz which is about their medical practice concerning vaccination against tetanus.

Locations

Country	Name	City	State
France	Service Urgence et Réanimation Pédiatrique Hôpital Femme Mère Enfant Groupement Hospitalier Est	Bron

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Tetanus vaccination coverage	Patient will have to answer a quiz which is about their vaccination against tetanus.	About 5 minutes